Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1.
Mol Ther Oncolytics. 2023 Feb 11;28:334-348. doi: 10.1016/j.omto.2023.02.003. eCollection 2023 Mar 16.
Mol Ther Oncolytics. 2023.
PMID: 36938544
Free PMC article.
Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus.
Ding J, Murad YM, Sun Y, Lee IF, Samudio I, Liu X, Jia WW, Zhao R.
Ding J, et al. Among authors: jia ww.
Viruses. 2022 Oct 23;14(11):2327. doi: 10.3390/v14112327.
Viruses. 2022.
PMID: 36366425
Free PMC article.
Item in Clipboard
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells.
Delwar Z, Tatsiy O, Chouljenko DV, Lee IF, Liu G, Liu X, Bu L, Ding J, Singh M, Murad YM, Jia WW.
Delwar Z, et al. Among authors: jia ww.
Vaccines (Basel). 2023 Dec 2;11(12):1805. doi: 10.3390/vaccines11121805.
Vaccines (Basel). 2023.
PMID: 38140209
Free PMC article.
Item in Clipboard
Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen.
Li X, Wang H, Lai W, Liao J, Mo W, Huang K, He L, Liang X, Yu Z, Xu J, Hua X, Hou F, Ding J, Jia WW, Zhang K, Wang Y.
Li X, et al. Among authors: jia ww.
Immunology. 2024 Mar 12. doi: 10.1111/imm.13777. Online ahead of print.
Immunology. 2024.
PMID: 38471664
Item in Clipboard
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes.
Chouljenko DV, Ding J, Lee IF, Murad YM, Bu X, Liu G, Delwar Z, Sun Y, Yu S, Samudio I, Zhao R, Jia WW.
Chouljenko DV, et al. Among authors: jia ww.
Biomedicines. 2020 Nov 9;8(11):484. doi: 10.3390/biomedicines8110484.
Biomedicines. 2020.
PMID: 33182232
Free PMC article.
Item in Clipboard
Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases.
Qiu Y, Qin A, Zhao R, Ding J, Jia WW, Singh M, Murad Y, Tan Q, Kichenadasse G.
Qiu Y, et al. Among authors: jia ww.
Oncol Lett. 2024 Apr 3;27(6):244. doi: 10.3892/ol.2024.14377. eCollection 2024 Jun.
Oncol Lett. 2024.
PMID: 38638849
Free PMC article.
Item in Clipboard
A 16bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1.
Feng D, Chen J, Yue Y, Zhu H, Xue J, Jia WW.
Feng D, et al.
J Mol Biol. 2006 Apr 21;358(1):38-45. doi: 10.1016/j.jmb.2006.01.029. Epub 2006 Jan 30.
J Mol Biol. 2006.
PMID: 16516232
Item in Clipboard
Cite
Cite